Cite
HARVARD Citation
Ferreri, A. et al. (2021). A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial. British journal of haematology. pp. 119-128. [Online].